✦ LIBER ✦

A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine–derived membrane material in patients with venous leg ulcers

✍ Scribed by Teresa J. Kelechi; Martina Mueller; Cheryl S. Hankin; Amy Bronstone; John Samies; Phyllis A. Bonham

Book ID: 116587968
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 546 KB
Volume: 66
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2011.01.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

46 A Phase 2a Randomized Placebo-Control

46 A Phase 2a Randomized Placebo-Controlled Double-Blind Multi-Center Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Patients With Moderately Active Ulcerative Colitis

✍ Severine Vermeire; Paul J. Rutgeerts; Geert R. D'Haens; Martine De Vos; Brian Br 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase IV randomized, double-blind, pla

A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efalizumab in patients with moderate to severe plaque psoriasis involving the scalp

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and pharmacodynamics of AT1001 in patients with Fabry disease and AT1001-responsive GLA mutations

✍ Mathews Adera; Chemise Overton; Pol Boudes 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A 3-month, randomized, double-blind, pla

A 3-month, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a highly optimized, capacitively coupled, pulsed electrical stimulator in patients with osteoarthritis of the knee

✍ D. Garland; P. Holt; J. Timothy Harrington; J. Caldwell; T. Zizic; J. Cholewczyn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 226 KB